|
Synonyms: Compound 28A [WO2021249534] | GDC2992 | RO7656594
Compound class:
Synthetic organic
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| GDC-2992 (formerly RO7656594) is a clinical candidate for the treatment of advanced/metastatic prostate cancer. |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT05800665 | A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer | Phase 1 Interventional | Genentech, Inc. | ||